Dominari Holdings
New York · Founded 1967
About Dominari Holdings
The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
Company Facts
- Founded: 1967
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $157.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2025)
- Ticker: nasdaq:DOMH
- Website: dominariholdings.com
- Phone: +1 212 393 4540
Industries & Categories
Angel Investment, Financial Services, Health Care, Impact Investing, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/dominari-holdings-39509 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.